Boulder vaccine potency assay producer InDevR brings in financing to expand the commercialization of VaxArray technology.
InDevR has been servicing influenza vaccine producers with its novel multiplexed potency assay by providing game changing information to streamline production. In preparation for commercial expansion, they are utilizing UBC’s market positioning sprint program to help determine where to apply future investments in sales, marketing, and product development.
InDevR is a global leader in progressive new analytical technologies that enables accelerated development and manufacturing of vaccines and other biotherapeutics. Key products include the VaxArray portfolio of game-changing multiplexed potency assays for vaccines and the Cypher One system for digital imaging and automated interpretation of hemagglutination assays.